Colombia vs Ghana: HIV/AIDS deaths averted by antiretroviral therapy
Colombia
11,670 deaths
in 2023
Ghana
12,358 deaths
in 2024
Colombia rank
21st
Ghana rank
20th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Colombia
- Ghana
How they compare
Ghana currently reports 12,358 deaths against 11,670 deaths in Colombia, a difference of 688 deaths.
That makes Ghana's figure about 1.1 times Colombia's.
The two have swapped places 4 times across 34 shared years of data; in 1990 it was Ghana ahead.
Colombia ranks 21st and Ghana ranks 20th of 157 countries.
Across the 4 decades both report, Colombia averaged higher in 1 and Ghana in 2.
Head to head by decade
| Decade | Colombia | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,534 deaths | 1,525 deaths | 8.52 deaths | Colombia |
| 2010s | 6,492 deaths | 9,063 deaths | 2,570 deaths | Ghana |
| 2020s | 10,904 deaths | 11,243 deaths | 338.88 deaths | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Colombia or Ghana?
- Ghana, at 12,358 deaths against 11,670 deaths in Colombia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Colombia and Ghana?
- 688 deaths, with Ghana ahead.
- How many years of comparable data are there for Colombia and Ghana?
- 34 years are reported by both, from 1990 to 2023.
- How do Colombia and Ghana rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Colombia ranks 21st and Ghana ranks 20th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.